Cargando…

The Immunological and Virological Consequences of Planned Treatment Interruptions in Children with HIV Infection

OBJECTIVES: To evaluate the immunological and viral consequences of planned treatment interruptions (PTI) in children with HIV. DESIGN: This was an immunological and virological sub-study of the Paediatric European Network for Treatment of AIDS (PENTA) 11 trial, which compared CD4-guided PTI of anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klein, Nigel, Sefe, Delali, Mosconi, Ilaria, Zanchetta, Marisa, Castro, Hannah, Jacobsen, Marianne, Jones, Hannah, Bernardi, Stefania, Pillay, Deenan, Giaquinto, Carlo, Walker, A. Sarah, Gibb, Diana M., De Rossi, Anita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806774/ https://www.ncbi.nlm.nih.gov/pubmed/24194841 http://dx.doi.org/10.1371/journal.pone.0076582

Ejemplares similares

Long‐term clinical, virological and immunological outcomes following planned treatment interruption in HIV‐infected children
por: Freguja, R, et al.
Publicado: (2020)

Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1
por: Ricci, Elisabetta, et al.
Publicado: (2010)

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B
por: Rosás-Umbert, Miriam, et al.
Publicado: (2017)

Virology and Immunology of Bats
por: Schountz, Tony
Publicado: (2013)

Structured Treatment Interruptions and Low Doses of IL-2 in Patients with Primary HIV Infection. Inflammatory, Virological and Immunological Outcomes
por: Sued, Omar, et al.
Publicado: (2015)

Plasticity of the Immune System in Children Following Treatment Interruption in HIV-1 Infection
por: Sandgaard, Katrine Schou, et al.
Publicado: (2021)

HIV-1 with Multiple CCR5/CXCR4 Chimeric Receptor Use Is Predictive of Immunological Failure in Infected Children
por: Cavarelli, Mariangela, et al.
Publicado: (2008)

Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children
por: Domínguez-Rodríguez, Sara, et al.
Publicado: (2022)

Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
por: Castro, Hannah, et al.
Publicado: (2012)

Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics
por: Joshi, Shivali S., et al.
Publicado: (2020)

Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure
por: Schultze, Anna, et al.
Publicado: (2014)

Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring
por: von Wyl, Viktor, et al.
Publicado: (2012)

Interrupted Blood Feeding in Ticks: Causes and Consequences
por: Tahir, Djamel, et al.
Publicado: (2020)

Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children
por: Harrison, Linda, et al.
Publicado: (2012)

The prognosis of patients with dissociated virological and immunological responses to HAART
por: Jevtovic, DJ, et al.
Publicado: (2010)

Immunological and virological aspects of HIV cell-to-cell transfer
por: Schwartz, Olivier
Publicado: (2009)

Virology and Immunology Researchers Evolve with the Viruses We Study
por: Russell, Rodney S.
Publicado: (2020)

Insights into the virologic and immunologic features of SARS-COV-2
por: Polat, Ceylan, et al.
Publicado: (2021)

Interrupted time-series analysis showed unintended consequences of non-pharmaceutical interventions on pediatric hospital admissions
por: Moore, Hannah C, et al.
Publicado: (2022)

The Effect of HIV Treatment Interruption on Subsequent Immunological Response
por: Thomadakis, Christos, et al.
Publicado: (2023)

Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies
por: Cotugno, Nicola, et al.
Publicado: (2021)

The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data
por: Dolling, David I., et al.
Publicado: (2017)

Deciphering SARS-CoV-2 Virologic and Immunologic Features
por: Lebeau, Grégorie, et al.
Publicado: (2020)

Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses
por: Durán-Ferrer, Manuel, et al.
Publicado: (2022)

Host factors and early treatments to restrict paediatric HIV infection and early disease progression
por: Gianesin, Ketty, et al.
Publicado: (2015)

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients
por: Fehér, Csaba, et al.
Publicado: (2019)

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence
por: Zamor, Philippe J., et al.
Publicado: (2021)

Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity
por: McGuinty, Michaeline, et al.
Publicado: (2020)

Biological Aging and Immune Senescence in Children with Perinatally Acquired HIV
por: Dalzini, Annalisa, et al.
Publicado: (2020)

HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse
por: Vasiliver-Shamis, Gaia, et al.
Publicado: (2010)

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda
por: Tukei, Vincent J, et al.
Publicado: (2013)

Immunological and Virological Mechanisms of Vaccine-Mediated Protection Against SIV and HIV
por: Roederer, Mario, et al.
Publicado: (2013)

Clinical, immunological, and virological outcomes of pediatric antiretroviral therapy in central China
por: Zheng, Junwen, et al.
Publicado: (2014)

Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection
por: Ananworanich, Jintanat, et al.
Publicado: (2016)

SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
por: Baay, Marc, et al.
Publicado: (2020)

Clinical, virological and immunological evolution of the olfactory and gustatory dysfunction in COVID-19
por: Maiorano, Eugenia, et al.
Publicado: (2022)

Longitudinal Virological and Immunological Profile in a Case of Human Monkeypox Infection
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2022)

Flow cytometry and immunohistochemistry of the mouse dural meninges for immunological and virological assessments
por: Roussel-Queval, Annie, et al.
Publicado: (2023)

HIV post-treatment controllers have distinct immunological and virological features
por: Etemad, Behzad, et al.
Publicado: (2023)

Lymphatic Interrupted: Do We Really Understand the Risks and Consequences?
por: Mittendorf, Elizabeth A., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_hva443gj9cnhirclciq4s9aa7n